317 related articles for article (PubMed ID: 27021772)
1. Medulloblastoma: Tumor Biology and Relevance to Treatment and Prognosis Paradigm.
Coluccia D; Figuereido C; Isik S; Smith C; Rutka JT
Curr Neurol Neurosci Rep; 2016 May; 16(5):43. PubMed ID: 27021772
[TBL] [Abstract][Full Text] [Related]
2. Recurrence patterns across medulloblastoma subgroups: an integrated clinical and molecular analysis.
Ramaswamy V; Remke M; Bouffet E; Faria CC; Perreault S; Cho YJ; Shih DJ; Luu B; Dubuc AM; Northcott PA; Schüller U; Gururangan S; McLendon R; Bigner D; Fouladi M; Ligon KL; Pomeroy SL; Dunn S; Triscott J; Jabado N; Fontebasso A; Jones DT; Kool M; Karajannis MA; Gardner SL; Zagzag D; Nunes S; Pimentel J; Mora J; Lipp E; Walter AW; Ryzhova M; Zheludkova O; Kumirova E; Alshami J; Croul SE; Rutka JT; Hawkins C; Tabori U; Codispoti KE; Packer RJ; Pfister SM; Korshunov A; Taylor MD
Lancet Oncol; 2013 Nov; 14(12):1200-7. PubMed ID: 24140199
[TBL] [Abstract][Full Text] [Related]
3. Medulloblastoma in the age of molecular subgroups: a review.
Juraschka K; Taylor MD
J Neurosurg Pediatr; 2019 Oct; 24(4):353-363. PubMed ID: 31574483
[TBL] [Abstract][Full Text] [Related]
4. Molecular Classification of Medulloblastoma.
Kijima N; Kanemura Y
Neurol Med Chir (Tokyo); 2016 Nov; 56(11):687-697. PubMed ID: 27238212
[TBL] [Abstract][Full Text] [Related]
5. Shedding light on adult medulloblastoma: current management and opportunities for advances.
Brandes AA; Franceschi E
Am Soc Clin Oncol Educ Book; 2014; ():e82-7. PubMed ID: 24857151
[TBL] [Abstract][Full Text] [Related]
6. Molecular Subgrouping of Medulloblastoma: Impact Upon Research and Clinical Practice.
Gupta T; Shirsat N; Jalali R
Curr Pediatr Rev; 2015; 11(2):106-19. PubMed ID: 26133181
[TBL] [Abstract][Full Text] [Related]
7. Childhood medulloblastoma: the paradigm shift in molecular stratification and treatment profile.
Sadighi Z; Vats T; Khatua S
J Child Neurol; 2012 Oct; 27(10):1302-7. PubMed ID: 22826514
[TBL] [Abstract][Full Text] [Related]
8. SnapShot: Medulloblastoma.
Rusert JM; Wu X; Eberhart CG; Taylor MD; Wechsler-Reya RJ
Cancer Cell; 2014 Dec; 26(6):940-940.e1. PubMed ID: 25490452
[TBL] [Abstract][Full Text] [Related]
9. Childhood medulloblastoma.
Massimino M; Biassoni V; Gandola L; Garrè ML; Gatta G; Giangaspero F; Poggi G; Rutkowski S
Crit Rev Oncol Hematol; 2016 Sep; 105():35-51. PubMed ID: 27375228
[TBL] [Abstract][Full Text] [Related]
10. Molecular stratifications, biomarker candidates and new therapeutic options in current medulloblastoma treatment approaches.
Menyhárt O; Győrffy B
Cancer Metastasis Rev; 2020 Mar; 39(1):211-233. PubMed ID: 31970590
[TBL] [Abstract][Full Text] [Related]
11. Overview and recent advances in the targeting of medulloblastoma cancer stem cells.
Paul MR; Zage PE
Expert Rev Anticancer Ther; 2021 Sep; 21(9):957-974. PubMed ID: 34047251
[No Abstract] [Full Text] [Related]
12. New perspectives in the treatment of adult medulloblastoma in the era of molecular oncology.
Brandes AA; Bartolotti M; Marucci G; Ghimenton C; Agati R; Fioravanti A; Mascarin M; Volpin L; Ammannati F; Masotto B; Gardiman MP; De Biase D; Tallini G; Crisi G; Bartolini S; Franceschi E
Crit Rev Oncol Hematol; 2015 Jun; 94(3):348-59. PubMed ID: 25600839
[TBL] [Abstract][Full Text] [Related]
13. Medulloblastoma: From Molecular Subgroups to Molecular Targeted Therapies.
Wang J; Garancher A; Ramaswamy V; Wechsler-Reya RJ
Annu Rev Neurosci; 2018 Jul; 41():207-232. PubMed ID: 29641939
[TBL] [Abstract][Full Text] [Related]
14. Medulloblastoma molecular dissection: the way toward targeted therapy.
Remke M; Ramaswamy V; Taylor MD
Curr Opin Oncol; 2013 Nov; 25(6):674-81. PubMed ID: 24076581
[TBL] [Abstract][Full Text] [Related]
15. Medulloblastoma: tumorigenesis, current clinical paradigm, and efforts to improve risk stratification.
Polkinghorn WR; Tarbell NJ
Nat Clin Pract Oncol; 2007 May; 4(5):295-304. PubMed ID: 17464337
[TBL] [Abstract][Full Text] [Related]
16. Medulloblastoma: what is the role of molecular genetics?
Entz-Werle N; Carli ED; Ducassou S; Legrain M; Grill J; Dufour C
Expert Rev Anticancer Ther; 2008 Jul; 8(7):1169-81. PubMed ID: 18588461
[TBL] [Abstract][Full Text] [Related]
17. Medulloblastoma: From Myth to Molecular.
Ramaswamy V; Taylor MD
J Clin Oncol; 2017 Jul; 35(21):2355-2363. PubMed ID: 28640708
[TBL] [Abstract][Full Text] [Related]
18. Tailoring Medulloblastoma Treatment Through Genomics: Making a Change, One Subgroup at a Time.
Holgado BL; Guerreiro Stucklin A; Garzia L; Daniels C; Taylor MD
Annu Rev Genomics Hum Genet; 2017 Aug; 18():143-166. PubMed ID: 28475368
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathological features of medulloblastoma: an overview with an emphasis on molecular biology.
de Haas TG; Kool M
Clin Neuropathol; 2007; 26(3):93-110. PubMed ID: 19157001
[TBL] [Abstract][Full Text] [Related]
20. Matching mice to malignancy: molecular subgroups and models of medulloblastoma.
Lau J; Schmidt C; Markant SL; Taylor MD; Wechsler-Reya RJ; Weiss WA
Childs Nerv Syst; 2012 Apr; 28(4):521-32. PubMed ID: 22315164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]